About this book:

Edwards Lifesciences chronicles the inspiring journey of a pioneering American company, from its audacious beginnings in the 1950s with electrical engineer Miles "Lowell" Edwards, who set out to build the world's first artificial heart. This vision quickly led to a pivotal partnership with Dr. Albert Starr, resulting in the groundbreaking Starr-Edwards valve in 1960—the first commercially successful artificial heart valve. The book traces the company's evolution from its founding as Edwards Laboratories in Santa Ana, California, through strategic partnerships, periods under American Hospital Supply and Baxter International, and its re-emergence as an independent, publicly traded entity in 2000. This narrative highlights how Edwards built a robust portfolio in heart valve technology, expanded into critical care with innovations like the Swan-Ganz catheter, and ultimately led the Transcatheter Aortic Valve Replacement (TAVR) revolution with its Sapien valve, fundamentally changing cardiac care.

Beyond its scientific and commercial achievements, "Edwards Lifesciences" delves into the core values and leadership that have steered the company forward. It explores Edwards' unwavering commitment to research and development, its strategic use of acquisitions to accelerate innovation in areas like mitral and tricuspid valve therapies, and its extensive global footprint in manufacturing and operations. The book also emphasizes the company's deep-rooted patient-first culture, its stringent ethical standards, and its profound dedication to corporate social responsibility through the Edwards Lifesciences Foundation and the "Every Heartbeat Matters" initiative, which has positively impacted millions of underserved individuals worldwide. Ultimately, it’s a story of resilience, adaptation, and an enduring legacy that continues to redefine what's possible in cardiovascular medicine, one heartbeat at a time.

What You'll Find Inside:

• **Pioneering Heart Valve Innovation:** Discover how Edwards Lifesciences originated with the world's first commercially successful artificial heart valve (Starr-Edwards Valve) and evolved to become a leader in surgical and transcatheter heart valve replacement and repair technologies.
• **The Transcatheter Revolution (TAVR):** Learn about the development and global impact of the Edwards Sapien valve, which revolutionized the treatment of aortic stenosis by offering a minimally invasive alternative to open-heart surgery, and its continuous evolution through multiple generations.
• **Strategic Growth Through R&D and Acquisitions:** Explore how the company maintains its market leadership through substantial investments in internal research and development, alongside strategic acquisitions of pioneering technologies in areas like transcatheter mitral/tricuspid therapies and heart failure management.
• **Commitment to Patient-Centricity and Ethics:** Understand the foundational role of the Edwards Lifesciences Credo and core values, emphasizing integrity, patient-first philosophy, and ethical conduct, alongside significant philanthropic efforts through the 'Every Heartbeat Matters' initiative.
• **Navigating Industry Dynamics and Achieving Market Leadership:** Examine the company's resilience and adaptability in a highly competitive and regulated medical technology landscape, including its journey to S&P 500 status and strategic portfolio adjustments like the divestiture of its Critical Care business.

Who's It For:

This book is ideal for anyone interested in the history and evolution of medical technology, particularly in cardiology and critical care. It will appeal to healthcare professionals, medical device industry executives, investors tracking healthcare and biotech sectors, and students of business, engineering, and medicine. Readers passionate about corporate innovation, social responsibility, and the profound impact of a patient-first business philosophy will also find this book highly engaging.